Group 1 - Samsung Medical announced that as of the disclosure date, its board member and secretary, Ms. Guo Su, holds 600,000 shares, accounting for 0.04% of the total share capital [1] - Ms. Guo plans to reduce her holdings by up to 150,000 shares, which is no more than 0.01% of the total share capital, due to personal financial needs [1] - The reduction will occur within three months after the announcement, with a maximum of 25% of her total holdings being sold [1] Group 2 - For the year 2024, Samsung Medical's revenue composition is as follows: manufacturing accounts for 76.16%, medical services for 22.31%, other businesses for 1.48%, and financial services for 0.04% [1] - As of the report, Samsung Medical has a market capitalization of 34.3 billion yuan [1]
三星医疗:股东计划减持公司股份不超过15万股